Library
On the use of open-label studies for the evaluation of cannabis-based products for the treatment of long COVID.
6 July 2026. doid: 10.1111/bcp.16169
Gorbenko AA, Cohen AA
View publicationAdvancing the boundaries of clinical drug development
Wondering how we can help you? Reach out to us.
